CME Group Inc (CME) Director Sells $224,774.75 in Stock

CME Group Inc (NASDAQ:CME) Director Jeffrey M. Bernacchi sold 1,501 shares of the stock in a transaction on Thursday, November 30th. The stock was sold at an average price of $149.75, for a total transaction of $224,774.75. Following the sale, the director now directly owns 60,194 shares in the company, valued at $9,014,051.50. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link.

CME Group Inc (CME) opened at $150.79 on Friday. The company has a current ratio of 1.05, a quick ratio of 1.05 and a debt-to-equity ratio of 0.11. The stock has a market cap of $51,135.15, a price-to-earnings ratio of 31.55, a price-to-earnings-growth ratio of 3.10 and a beta of 0.72. CME Group Inc has a twelve month low of $113.27 and a twelve month high of $152.14.

CME Group (NASDAQ:CME) last posted its quarterly earnings data on Thursday, October 26th. The financial services provider reported $1.19 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $1.16 by $0.03. The business had revenue of $890.80 million for the quarter, compared to the consensus estimate of $890.22 million. CME Group had a net margin of 40.94% and a return on equity of 7.89%. The company’s revenue was up 5.8% compared to the same quarter last year. During the same period last year, the firm posted $1.05 earnings per share. equities research analysts predict that CME Group Inc will post 4.78 EPS for the current year.

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, December 27th. Shareholders of record on Friday, December 8th will be issued a dividend of $0.66 per share. This represents a $2.64 annualized dividend and a yield of 1.75%. The ex-dividend date is Thursday, December 7th. CME Group’s payout ratio is 59.86%.

CME has been the topic of a number of recent analyst reports. Barclays initiated coverage on shares of CME Group in a report on Friday, September 8th. They set an “overweight” rating and a $139.00 price target on the stock. BidaskClub downgraded shares of CME Group from a “buy” rating to a “hold” rating in a report on Friday, September 1st. UBS reissued a “buy” rating and set a $135.00 price target (up from $134.00) on shares of CME Group in a report on Wednesday, September 6th. Citigroup increased their price target on shares of CME Group from $138.00 to $155.00 and gave the stock a “buy” rating in a report on Thursday, October 19th. Finally, Wells Fargo & Company increased their price target on shares of CME Group from $130.00 to $145.00 and gave the stock a “market perform” rating in a report on Wednesday, October 4th. One research analyst has rated the stock with a sell rating, four have issued a hold rating and seven have given a buy rating to the stock. CME Group currently has an average rating of “Buy” and a consensus price target of $141.75.

Institutional investors and hedge funds have recently bought and sold shares of the business. Fiduciary Trust Co. purchased a new position in CME Group during the second quarter valued at $105,000. Quadrant Capital Group LLC lifted its holdings in CME Group by 13.6% during the second quarter. Quadrant Capital Group LLC now owns 944 shares of the financial services provider’s stock valued at $111,000 after purchasing an additional 113 shares in the last quarter. Valeo Financial Advisors LLC purchased a new position in CME Group during the third quarter valued at $124,000. San Francisco Sentry Investment Group CA purchased a new position in CME Group during the second quarter valued at $129,000. Finally, People s United Financial Inc. raised its position in shares of CME Group by 11.5% in the second quarter. People s United Financial Inc. now owns 1,063 shares of the financial services provider’s stock valued at $133,000 after buying an additional 110 shares during the last quarter. 83.08% of the stock is currently owned by institutional investors and hedge funds.

COPYRIGHT VIOLATION WARNING: This news story was originally reported by Community Financial News and is owned by of Community Financial News. If you are accessing this news story on another website, it was copied illegally and republished in violation of US and international trademark and copyright legislation. The original version of this news story can be accessed at https://www.com-unik.info/2017/12/03/cme-group-inc-cme-director-sells-224774-75-in-stock.html.

CME Group Company Profile

CME Group Inc, through its exchanges, provides products across all asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural products and metals. The Company’s segment primarily consists of the Chicago Mercantile Exchange Inc (CME), Board of Trade of the City of Chicago, Inc (CBOT), New York Mercantile Exchange, Inc (NYMEX) and Commodity Exchange, Inc (COMEX) exchanges.

Insider Buying and Selling by Quarter for CME Group (NASDAQ:CME)

What are top analysts saying about CME Group Inc? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for CME Group Inc and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit